Net Cash Provided by (Used in) Operating Activities |
-3.29K |
USD |
+94.6% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
500M |
shares |
0% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares, Issued |
91.4M |
shares |
0% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-3.62K |
USD |
+94.1% |
Q1 2025 |
Q1 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
7.11M |
USD |
-0.51% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
7.11M |
USD |
-0.51% |
Q4 2024 |
FY 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-346K |
USD |
+20.8% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
6.93M |
USD |
-0.03% |
Q4 2024 |
FY 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q1 2025 |
Q1 2025 |
Preferred Stock, Shares Authorized |
250M |
shares |
0% |
Q1 2025 |
Q1 2025 |
Additional Paid in Capital |
1.49M |
USD |
+0.11% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2024 |
FY 2024 |
Share-based Payment Arrangement, Expense |
1.58K |
USD |
-97% |
Q1 2025 |
Q1 2025 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q1 2025 |
Q1 2025 |